Lv11
30 积分 2024-01-19 加入
Pharmacokinetic models for first-in-human dose selection of immune-activating products in oncology
10小时前
待确认
Assessing ADC Plasma Stability by LC-MS Methods
28天前
已关闭
Assessing ADC Plasma Stability by LC-MS Methods
28天前
已关闭
Assessing ADC Plasma Stability by LC-MS Methods
28天前
已关闭
Discovery of TYRA-300: First Oral Selective FGFR3 Inhibitor for the Treatment of Urothelial Cancers and Achondroplasia
2个月前
已完结
Novel LC-MS/MS analysis of the GLP-1 analog semaglutide with its application to pharmacokinetics and brain distribution studies in rats
5个月前
已完结
Prediction of Human Drug Clearance from in Vitro and Preclinical Data Using Physiologically Based and Empirical Approaches
11个月前
已完结
Drug Design and Success of Prospective Mouse In Vitro–In Vivo Extrapolation (IVIVE) for Predictions of Plasma Clearance (CLp) from Hepatocyte Intrinsic Clearance (CLint)
11个月前
已完结
Process and System Clearances in Pharmacokinetic Models: Our Basic Clearance Concepts Are Correct
11个月前
已完结
Drug Design and Success of Prospective Mouse In Vitro–In Vivo Extrapolation (IVIVE) for Predictions of Plasma Clearance (CLp) from Hepatocyte Intrinsic Clearance (CLint)
11个月前
已完结
皖公网安备34019202002308
